SOURCE: Trxade Group, Inc.

June 12, 2014 09:00 ET

TRXADE GROUP, INC Files Form 10 With U.S. Securities and Exchange Commission

Trxade Group Takes First Step to Become Fully Reporting

TAMPA, FL--(Marketwired - Jun 12, 2014) - Trxade Group, Inc. (PINKSHEETS: XCEL), a web-based pharmaceutical marketplace engaged in promoting and enabling trade among independent pharmacies and large pharmaceutical suppliers nationally, announced today that it has filed a Form 10 Registration Statement under the Securities Exchange Act of 1934 (the "Exchange Act") with the U.S. Securities and Exchange Commission (SEC). The Registration Statement on Form 10 includes detailed information about Trxade, including Trxade's audited 2013 and 2012 financial statements together with the report by the company's independent registered public accounting firm, and Trxade's unaudited interim financial statements as of, and for, the three months ended March 31, 2014.

The filing is an important and necessary first step in Trxade Group becoming an SEC reporting company.

The company's common stock is currently quoted on the OTC Markets (Pink Sheets) under the symbol "XCEL" Once the SEC's comments, if any, to the Form 10 have been addressed, Trxade Group anticipates that a Form 15c2-11 will be submitted by a market maker to allow for the quotation of its common stock on the OTCBB or OTCQB.

Suren Ajjarapu, CEO of Trxade Group, said, "I couldn't be more excited for shareholders. This really represents two major milestones for both the company as well as investors. Becoming a fully reporting company allows us to move to the OTCBB (OTCQB) markets, an important step in our plan to ultimately list on the NASDAQ, if we can ramp up our revenues to meet the minimum listing requirements. We are very excited about our future opportunities in this huge nationwide market of independent pharmacies."

As a reporting company, Trxade Group will be required to file annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K. In addition, the company will be required to solicit proxies for its annual meetings in accordance with Section 14 of the Exchange Act and its management will be required to file reports with respect to their transactions in the company's common stock.

Mr. Ajjarapu continued, " As a reporting company with the appropriate team of advisers now in place, we will be in a position to provide investors with enhanced disclosure regarding Trxade Group and its operations."

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities of Trxade, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Investor Signup future Press Release Distribution by e-Mail

Shareholders and interested investors are invited to be added to the corporate e-mail database for future press releases and industry updates by signing up on the website or by sending an e-mail with "XCEL" in the subject line to

About Trxade Group, Inc
Headquartered in Tampa, Florida, Trxade Group, Inc. is a web based market platform that enables trade among healthcare buyers and sellers of pharmaceuticals, accessories and services. Please visit us at

Forward-Looking Statements

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. Except as may be required by applicable law, we assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Contact Information